# Intelligent Bio Solutions Inc.: filings

INBS · Nasdaq · CIK 1725430 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/inbs.md) · [Financials](/companies/inbs/financials.md) · [Filings](/companies/inbs/filings.md) · [Insiders](/companies/inbs/insiders.md)

## Reports and events: 228 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 167, 4 62, CORRESP 30, UPLOAD 28, S-1/A 19, 10-Q 17, 3 17, EFFECT 11, 424B5 9, 424B3 7, DEF 14A 7, PRE 14A 7, S-3 7, 10-K 6, SC 13G 6, 10-K/A 5, D 5, DEFA14A 5, S-8 5, DOS/A 4, DOSLTR 4, S-1 4, SC 13G/A 4, ARS 3, FWP 3, SCHEDULE 13G/A 3, 1-A/A 2, 424B4 2, 4/A 2, 8-K/A 2, 1-A 1, 1-A-W 1, 1-Z 1, 8-A12B 1, CERT 1, DOS 1, DRS 1, QUALIF 1, S-1MEF 1, S-3/A 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 21:00 ET | [10-K/A](/filings/0001493152-26-047925.md) | Annual report, amended, period 2026-06-30 | 0001493152-26-047925 |
| 2026-10-13 | 21:00 ET | [8-K](/filings/0001493152-26-046863.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-046863 |
| 2026-09-11 | 21:00 ET | [8-K](/filings/0001493152-26-042411.md) | 8.01 Other events | 0001493152-26-042411 |
| 2026-09-09 | 12:50 ET | [8-K](/filings/0001493152-26-041901.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041901 |
| 2026-09-02 | 21:00 ET | [8-K](/filings/0001493152-26-041253.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041253 |
| 2026-09-01 | 21:10 ET | [8-K](/filings/0001493152-26-041055.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041055 |
| 2026-08-28 | 21:20 ET | [8-K](/filings/0001493152-26-040656.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040656 |
| 2026-08-19 | 12:50 ET | [8-K](/filings/0001493152-26-039140.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-039140 |
| 2026-08-19 | 12:30 ET | [10-K](/filings/0001493152-26-039136.md) | Annual report, period 2026-06-30 | 0001493152-26-039136 |
| 2026-08-11 | 21:29 ET | [8-K](/filings/0001493152-26-037206.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037206 |
| 2026-08-05 | 12:55 ET | [8-K](/filings/0001493152-26-036112.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036112 |
| 2026-08-03 | 21:22 ET | [8-K](/filings/0001493152-26-035861.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035861 |
| 2026-08-03 | 21:20 ET | [8-K](/filings/0001493152-26-035860.md) | 8.01 Other events | 0001493152-26-035860 |
| 2026-07-23 | 21:00 ET | [8-K](/filings/0001493152-26-034428.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034428 |
| 2026-07-21 | 12:50 ET | [8-K](/filings/0001493152-26-034018.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034018 |
| 2026-06-16 | 20:30 ET | [8-K](/filings/0001493152-26-028898.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028898 |
| 2026-06-02 | 12:48 ET | [8-K](/filings/0001493152-26-026780.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026780 |
| 2026-05-14 | 01:08 ET | [8-K](/filings/0001493152-26-022823.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022823 |
| 2026-05-13 | 12:30 ET | [10-Q](/filings/0001493152-26-022617.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022617 |
| 2026-04-20 | 12:00 ET | [8-K](/filings/0001493152-26-018002.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018002 |
| 2026-03-23 | 20:30 ET | [8-K](/filings/0001493152-26-012173.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012173 |
| 2026-02-25 | 14:15 ET | [8-K](/filings/0001493152-26-007973.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007973 |
| 2026-02-12 | 13:55 ET | [8-K](/filings/0001493152-26-006317.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-006317 |
| 2026-02-12 | 13:31 ET | [10-Q](/filings/0001493152-26-006311.md) | Quarterly report, period 2025-12-31 | 0001493152-26-006311 |
| 2026-02-05 | 13:53 ET | [8-K](/filings/0001493152-26-005210.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-005210 |
| 2026-01-28 | 22:15 ET | [8-K](/filings/0001493152-26-004068.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-004068 |
| 2026-01-08 | 22:00 ET | [8-K](/filings/0001493152-26-000984.md) | 8.01 Other events | 0001493152-26-000984 |
| 2026-01-02 | 22:10 ET | [8-K](/filings/0001493152-26-000176.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000176 |
| 2025-12-31 | 21:30 ET | [8-K](/filings/0001493152-25-029812.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-029812 |
| 2025-12-16 | 22:15 ET | [8-K](/filings/0001493152-25-028003.md) | 3.01 Delisting notice | 0001493152-25-028003 |
| 2025-12-12 | 22:05 ET | [8-K](/filings/0001493152-25-027534.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-027534 |
| 2025-12-02 | 13:00 ET | [8-K](/filings/0001493152-25-025665.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025665 |
| 2025-11-28 | 22:00 ET | [8-K](/filings/0001493152-25-025410.md) | 3.02 Unregistered sale of equity | 0001493152-25-025410 |
| 2025-11-12 | 22:15 ET | [8-K](/filings/0001493152-25-022005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022005 |
| 2025-11-12 | 13:20 ET | [10-Q](/filings/0001493152-25-021751.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021751 |
| 2025-11-07 | 22:20 ET | [8-K](/filings/0001493152-25-021323.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021323 |
| 2025-10-30 | 21:15 ET | [8-K](/filings/0001493152-25-020262.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020262 |
| 2025-10-21 | 20:30 ET | [8-K](/filings/0001493152-25-018806.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-018806 |
| 2025-09-26 | 12:45 ET | [8-K](/filings/0001493152-25-015068.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-015068 |
| 2025-09-25 | 21:00 ET | [8-K](/filings/0001493152-25-014961.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-014961 |
| 2025-09-19 | 20:05 ET | [DEF 14A](/filings/0001493152-25-014245.md) | Proxy statement, period 2025-09-19 | 0001493152-25-014245 |
| 2025-09-17 | 12:48 ET | [8-K](/filings/0001493152-25-013836.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013836 |
| 2025-08-15 | 21:00 ET | [8-K](/filings/0001493152-25-012101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-012101 |
| 2025-08-15 | 12:31 ET | [10-K](/filings/0001641172-25-024279.md) | Annual report, period 2025-06-30 | 0001641172-25-024279 |
| 2025-08-07 | 21:00 ET | [8-K](/filings/0001493152-25-011706.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011706 |
| 2025-08-06 | 13:15 ET | [8-K](/filings/0001493152-25-011634.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011634 |
| 2025-07-28 | 21:30 ET | [8-K](/filings/0001641172-25-021200.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021200 |
| 2025-07-23 | 21:27 ET | [8-K](/filings/0001641172-25-020729.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-020729 |
| 2025-07-16 | 21:15 ET | [8-K](/filings/0001493152-25-011264.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011264 |
| 2025-07-15 | 21:15 ET | [8-K](/filings/0001641172-25-019745.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019745 |

Page 1 of 5. [Older](/companies/inbs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.